Loading...
XSHE300261
Market cap823mUSD
Jan 10, Last price  
6.27CNY
1D
-4.71%
1Q
-3.09%
Jan 2017
-2.79%
IPO
79.14%
Name

Aba Chemicals Corp

Chart & Performance

D1W1MN
XSHE:300261 chart
P/E
—
P/S
4.72
EPS
—
Div Yield, %
1.33%
Shrs. gr., 5y
-0.18%
Rev. gr., 5y
-6.67%
Revenues
1.28b
-36.09%
92,744,189163,609,897184,257,428230,168,133301,389,794410,931,866526,075,960627,151,001661,553,3281,207,829,0691,805,648,8081,664,423,7962,003,330,5812,071,740,0622,000,975,8991,278,848,252
Net income
-82m
L
12,662,43325,849,28839,667,00744,380,93349,370,08643,938,43050,519,58361,230,97016,205,15773,169,190160,624,23281,643,737161,014,430181,849,264202,948,039-82,293,803
CFO
-26m
L
8,550,26317,178,98125,298,58010,526,10730,095,03011,508,23284,640,62069,803,03221,109,407285,252,737307,852,99194,145,833338,139,531422,704,00881,067,227-25,854,790
Dividend
Jun 12, 20230.05 CNY/sh
Earnings
Jun 13, 2025

Profile

ABA Chemicals Corporation engages in the research and development, and production of plant protection, pharmaceutical intermediates, and nutritional and health products worldwide. The company offers plant protection products, such as plant growth regulator, herbicides, insecticide, and bactericide; pharmaceutical products, including pesticide and pharmaceutical intermediates; and nutrition products. ABA Chemicals Corporation was founded in 2003 and is based in Taicang, China.
URL
https://www.abachem.com/
IPO date
Sep 06, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,278,848
-36.09%
2,000,976
-3.42%
Cost of revenue
1,203,420
1,598,631
Unusual Expense (Income)
NOPBT
75,428
402,345
NOPBT Margin
5.90%
20.11%
Operating Taxes
(16,459)
24,974
Tax Rate
6.21%
NOPAT
91,887
377,371
Net income
(82,294)
-140.55%
202,948
11.60%
Dividends
(80,068)
Dividend yield
1.12%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
939,530
633,976
Long-term debt
170,892
252,920
Deferred revenue
26,766
29,195
Other long-term liabilities
35,270
2,531
Net debt
491,850
16,498
Cash flow
Cash from operating activities
(25,855)
81,067
CAPEX
(232,275)
Cash from investing activities
(233,878)
Cash from financing activities
127,442
FCF
(169,725)
53,669
Balance
Cash
262,637
451,799
Long term investments
355,935
418,599
Excess cash
554,630
770,349
Stockholders' equity
1,781,440
1,862,998
Invested Capital
2,992,163
2,617,767
ROIC
3.28%
15.45%
ROCE
2.10%
11.73%
EV
Common stock shares outstanding
954,685
954,686
Price
7.46
-32.37%
11.03
-42.43%
Market cap
7,121,947
-32.37%
10,530,182
-42.43%
EV
7,766,726
10,668,853
EBITDA
213,846
538,635
EV/EBITDA
36.32
19.81
Interest
35,481
38,100
Interest/NOPBT
47.04%
9.47%